Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA
Author:
Funder
Intercept Pharmaceuticals
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s10620-021-07219-4.pdf
Reference11 articles.
1. Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386:1565–1575. https://doi.org/10.1016/S0140-6736(15)00154-3.
2. Corpechot C, Chazouilleres O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361–1367. https://doi.org/10.1016/j.jhep.2011.02.031.
3. Carbone M, Nardi A, Flack S et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol. 2018;3:626–634. https://doi.org/10.1016/S2468-1253(18)30163-8.
4. Cheung AC, Lammers WJ, Murillo Perez CF, et al. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2019; Doi:https://doi.org/10.1016/j.cgh.2018.12.028
5. Lu M, Zhou Y, Haller IV, et al. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018;16:1342–1350 e1. Doi:https://doi.org/10.1016/j.cgh.2017.12.033
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score;European Journal of Gastroenterology & Hepatology;2024-03-25
2. Hirsutella sinensis mycelium polysaccharides attenuate the TGF-β1-induced epithelial-mesenchymal transition in human intrahepatic bile duct epithelial cells;International Journal of Biological Macromolecules;2024-01
3. The treatment of primary biliary cholangitis: from shadow to light;Therapeutic Advances in Gastroenterology;2024-01
4. Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival;Liver International;2023-05-08
5. Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms;Expert Review of Gastroenterology & Hepatology;2022-12-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3